Pfizer (Germany) Investor Sentiment

PFE Stock  EUR 23.60  0.01  0.04%   
Roughly 62% of Pfizer's investor base is looking to short. The analysis of current outlook of investing in Pfizer Inc suggests that many traders are alarmed regarding Pfizer's prospects. The current market sentiment, together with Pfizer's historical and current headlines, can help investors time the market. In addition, many technical investors use Pfizer Inc stock news signals to limit their universe of possible portfolio assets.
Pfizer stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pfizer daily returns and investor perception about the current price of Pfizer Inc as well as its diversification or hedging effects on your existing portfolios.
  
over a week ago at news.google.com         
Pfizer adds former JJ exec.to lead obesity efforts - Seeking Alpha
Google News at Macroaxis
over two weeks ago at news.google.com         
Pfizer Inc. Shares Sold by Checchi Capital Advisers LLC - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Allworth Financial LP Increases Stock Position in Pfizer Inc. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Guyasuta Investment Advisors Inc. Has 3.53 Million Stock Holdings in Pfizer Inc. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pfizer Shares Up 0.1 percent - Heres Why - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance - Business Wire
Google News at Macroaxis
over a month ago at news.google.com         
Pfizer Q4 Earnings Preview 5 Critical Business Issues To Consider - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Leerink Partnrs Has Negative Outlook for Pfizer Q4 Earnings - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Pfizer Stock Price Down 0.4 percent Following Analyst Downgrade - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Lock In A Phenomenal Yield With Pfizer - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Health Care Up as Traders Seek Out Less Rate-Sensitive Sectors -- Health Care Roundup - Marketscreen...
Google News at Macroaxis
over three months ago at news.google.com         
Pfizer Trading 0.3 percent Higher - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Can Pfizer Stock Rise 2x To 60 - Forbes
Google News at Macroaxis
over three months ago at news.google.com         
Pfizer Inc. Why Are Street Analysts Bullish On This Wide Moat Stock Now - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Pfizer Undervalued Healthcare Leader Poised For Further Recovery - Seeking Alpha
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pfizer that are available to investors today. That information is available publicly through Pfizer media outlets and privately through word of mouth or via Pfizer internal channels. However, regardless of the origin, that massive amount of Pfizer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pfizer news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pfizer relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pfizer's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pfizer alpha.

Pfizer Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated